COGT (Cogent Biosciences) GF Value Rank: 2 (As of Jul. 09, 2026) — 100% Above Median


COGT Cogent Biosciences Inc COGT
30 GF Score
Price $40.51
! 4 Warning Signs
View Full Analysis

What is Cogent Biosciences GF Value Rank?

Cogent Biosciences COGT +1.30% 30 GF Value Rank is 2 as of Jul. 09, 2026, which is 100% above its 10-year median of 1.00. GuruFocus rates COGT with a GF Score™ of 30/100. The stock has 4 warning signs investors should review.

Cogent Biosciences has the GF Value Rank of 2.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Cogent Biosciences GF Value Rank Related Terms

COGT vs SRRK, CGON, LGND: GF Value Rank Comparison

For the Biotechnology subindustry, Cogent Biosciences's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cogent Biosciences GF Value Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cogent Biosciences's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Cogent Biosciences's GF Value Rank falls into.


COGT
30GF Score
Cogent Biosciences Inc COGT
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 2 mean?
Cogent Biosciences (COGT) has a GF Value Rank of 2 as of Jul. 09, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Cogent Biosciences and its competitors. This is 100% above median its historical median of 1.00. Over the past decade, Cogent Biosciences' GF Value Rank has ranged from 1.00 to 2.00.
Is Cogent Biosciences' GF Value Rank too high?
Cogent Biosciences' current GF Value Rank of 2 is 100% above median its 10-year median of 1.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 2.00. Overall, Cogent Biosciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Cogent Biosciences' GF Value Rank compare to SRRK and CGON?
Cogent Biosciences' GF Value Rank of 2 can be compared against companies in the Biotechnology industry. Historically, Cogent Biosciences' own GF Value Rank has ranged from 1.00 to 2.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Biotechnology company?
A good GF Value Rank depends on the Biotechnology industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Cogent Biosciences and its competitors. Cogent Biosciences's current GF Value Rank is 2, which is 100% above median its own 10-year median of 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogent Biosciences stock overvalued right now?
Cogent Biosciences (COGT) has a current GF Value Rank of 2. The current GF Value Rank is 2, which is 100% above median its 10-year median of 1.00. Cogent Biosciences' overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Cogent Biosciences (COGT), the current GF Value Rank is 2 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
30GF Score

Get the complete analysis for COGT

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.51
Price